このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

PetVivo Holdings 将来の成長

Future 基準チェック /26

PetVivo Holdingsは、6.7%と79.8%でそれぞれ年率6.7%で利益と収益が成長すると予測される一方、EPSはgrowで15.5%年率。

主要情報

6.7%

収益成長率

15.5%

EPS成長率

Medical Equipment 収益成長	16.6%
収益成長率	79.8%
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	04 Mar 2024

今後の成長に関する最新情報

更新なし

Recent updates

Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky

Nov 11

Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?

Jul 26

PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M

Jun 29

We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth

Mar 23

業績と収益の成長予測

OTCPK:PETV - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
3/31/2026	9	-10	N/A	N/A	1
3/31/2024	3	-12	N/A	N/A	1
12/31/2023	1	-11	-8	-7	N/A
6/30/2023	1	-10	-8	-7	N/A
3/31/2023	1	-9	-7	-7	N/A
12/31/2022	1	-8	-8	-7	N/A
9/30/2022	0	-7	-7	-7	N/A
6/30/2022	0	-6	-6	-6	N/A
3/31/2022	0	-5	-4	-4	N/A
12/31/2021	0	-4	-3	-3	N/A
9/30/2021	0	-3	-2	-2	N/A
6/30/2021	0	-3	-1	-1	N/A
3/31/2021	0	-4	-1	-1	N/A
12/31/2020	0	-4	-1	-1	N/A
9/30/2020	0	-3	-1	-1	N/A
6/30/2020	0	-2	-1	-1	N/A
3/31/2020	0	-2	-1	0	N/A
12/31/2019	0	-3	-1	-1	N/A
9/30/2019	N/A	-3	-1	-1	N/A
6/30/2019	N/A	-3	-1	-1	N/A
3/31/2019	N/A	-5	-1	-1	N/A
12/31/2018	N/A	-4	-1	-1	N/A
9/30/2018	N/A	-4	-1	-1	N/A
6/30/2018	0	-4	-1	-1	N/A
3/31/2018	0	-2	-1	-1	N/A
12/31/2017	0	-2	0	0	N/A
9/30/2017	0	-2	N/A	0	N/A
6/30/2017	0	-16	N/A	0	N/A
3/31/2017	0	-16	N/A	0	N/A
12/31/2016	0	-17	N/A	0	N/A
9/30/2016	0	-17	N/A	0	N/A
6/30/2016	0	-3	N/A	0	N/A
3/31/2016	0	-4	N/A	-1	N/A
12/31/2015	0	-3	N/A	-1	N/A
9/30/2015	0	-3	N/A	-1	N/A
6/30/2015	0	-2	N/A	-1	N/A
3/31/2015	N/A	-2	N/A	0	N/A
12/31/2014	N/A	-38	N/A	0	N/A

アナリストによる今後の成長予測

収入対貯蓄率: PETV今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: PETV今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: PETV今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: PETVの収益 ( 79.8% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: PETVの収益 ( 79.8% ) 20%よりも速いペースで成長すると予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: PETVの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

PetVivo Holdings 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Recent updates

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from S&P TMI Index

PetVivo Holdings Receives Determination Letter from the Nasdaq Hearings Panel Due to Failure to Regain Compliance with the Nasdaq Listing Rule 5550(b) by April 1, 2024

PetVivo Holdings, Inc.(OTCPK:PETV) dropped from NASDAQ Composite Index

Petvivo Holdings, Inc. Appoints Garry Lowenthal as Its New Chief Financial Officer

PetVivo Holdings, Inc. has completed a Follow-on Equity Offering in the amount of $0.959033 million.

Third quarter 2024 earnings released: US$0.12 loss per share (vs US$0.23 loss in 3Q 2023)

PetVivo Holdings, Inc. to Report Q3, 2024 Results on Feb 12, 2024

PetVivo Holdings, Inc. Announces Release of Clinical Study Results Involving Canine Tolerance to Intra-Articular Injections of Spryng with OsteoCushion Technology

Petvivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

PetVivo Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Stockholders’ Equity Requirement Under Nasdaq Listing Rule 5550(b)(1)

New major risk - Market cap size

PetVivo Holdings, Inc. Approves Election of Diane Levitan as Member of the Board

New major risk - Financial position

Second quarter 2024 earnings released: US$0.28 loss per share (vs US$0.21 loss in 2Q 2023)

PetVivo Holdings, Inc. to Report Q2, 2024 Results on Nov 14, 2023

PetVivo Holdings, Inc., Annual General Meeting, Nov 17, 2023

Independent Chairman of the Board recently bought US$51k worth of stock

PetVivo Receives Notice of Allowance from United States Patent and Trademark Office for Key Patent Application

First quarter 2024 earnings released: US$0.25 loss per share (vs US$0.20 loss in 1Q 2023)

PetVivo Holdings, Inc. to Report Q1, 2024 Results on Aug 10, 2023

New minor risk - Share price stability

Full year 2023 earnings: EPS and revenues miss analyst expectations

PetVivo Holdings, Inc. to Report Fiscal Year 2023 Results on Jun 29, 2023

PetVivo Holdings, Inc. Begins Process to Pursue Approval of Biomatrix Particulate Technology for Initial Human Indication

Third quarter 2023 earnings released: US$0.23 loss per share (vs US$0.17 loss in 3Q 2022)

PetVivo Holdings, Inc. to Report Q3, 2023 Results on Feb 09, 2023

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Companies Like PetVivo Holdings (NASDAQ:PETV) Could Be Quite Risky

PetVivo Holdings, Inc. to Report Q2, 2023 Results on Nov 10, 2022

Petvivo Holding, Inc. Announces Spryng™ Now Available to Veternarians Through Mwi Animal Health

PetVivo Holdings, Inc., Annual General Meeting, Oct 14, 2022

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

PetVivo Holdings, Inc. to Report Q1, 2023 Results on Aug 11, 2022

PetVivo Holdings, Inc. Announces Board Appointments

Will PetVivo Holdings (NASDAQ:PETV) Spend Its Cash Wisely?

PetVivo Holdings GAAP EPS of -$0.57 beats by $0.37, revenue of $0.1M misses by $1.6M

Full year 2022 earnings: EPS and revenues miss analyst expectations

PetVivo Holdings, Inc. to Report Fiscal Year 2022 Results on Jun 29, 2022

We Think PetVivo Holdings (NASDAQ:PETV) Can Afford To Drive Business Growth

Third quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

PetVivo Holdings, Inc. to Report Q3, 2022 Results on Feb 10, 2022

Second quarter 2022 earnings released: US$0.13 loss per share (vs US$0.23 loss in 2Q 2021)

First quarter 2022 earnings released: US$0.071 loss per share (vs US$0.14 loss in 1Q 2021)

PetVivo Holdings Common Stock Deleted from Other OTC

High number of new directors

Petvivo Holdings, Inc. Enters into University Services Agreement with Colorado State University

PetVivo Holdings, Inc. announced that it has received $0.6 million in funding from RedDiamond Partners LLC

Petvivo Holdings, Inc. Appoints Dr. David B. Masters as Director of Science and Technology

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘